Skip to main content
Fig. 6 | Cancer Nanotechnology

Fig. 6

From: Synergistic action of curcumin and cisplatin on spinel ferrite/hierarchical MCM-41 nanocomposite against MCF-7, HeLa and HCT 116 cancer cell line

Fig. 6

EC50 analysis. Data from the cell viability assay (Fig. 5) were used to extrapolate EC50 of the following conditions: cisplatin, CuFe2O4/mesosilicalite/curcumin, CuFe2O4/mesosilicalite/curcumin/cisplatin, and CuFe2O4/MCM-41/curcumin/cisplatin. A, B Represent data from MCF7, C, D from HeLa, E, F from HCT116, and G, H from HFF cell lines. A, C, E, G) are the cell viability curves against Log concentration of each condition. B, D, F, H Represent the Log EC50, EC50, and R2 values of each group

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us